Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Cell and gene therapy developers must build continuity of engagement to create trust in the modalities, according to a report ...
Three 2026 Breakthrough Prize winners reflect on developing Luxturna, a gene therapy that treats blindness caused by rare ...
Scientists at the MRC Laboratory of Medical Sciences (LMS) have discovered a DNA-based “dimmer switch” that regulates the activity of a critical developmental gene, Cdx2. This work could pave the way ...
Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...
Yet although mammals like humans can’t do this, the evolutionary wiring for complete limb regeneration is seemingly conserved ...
HOUSTON and MIAMI, SEPTEMBER 5, 2025 ― The University of Texas MD Anderson Cancer Center and Phoenix SENOLYTIX, Inc., today announced a global cross-licensing agreement to facilitate work that will ...
For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without causing new health problems in the process. Now, a team of scientists from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results